Canaccord Adams initiates coverage on Palomar Medical Technologies (Nasdaq: PMTI) with a Buy. Price target $21.

Canaccord analyst says, "Palomar ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE